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Background/Aims: Cigarette smoking and abnormal blood lipids are major risk 
factors for cardiovascular disease. The results of previous studies on the relation-
ship between cigarette smoking and dyslipidemia are controversial. In the pres-
ent study, we investigated the independent association between cigarette smoking 
and blood lipid levels in a male Korean population.
Methods: A total of 1,932 men aged from 30 to 64 years old participated in the 
Cardiovascular and Metabolic Diseases Etiology Research Center cohort study. 
Smoking history was obtained by in-person interviews. In all regression models, 
measurements of triglyceride levels were log-transformed.
Results: Triglyceride levels were higher in current smokers than in never-smokers 
(median: 149 mg/dL vs. 115 mg/dL, p < 0.001) even after adjusting age, body mass 
index, alcohol intake, systolic blood pressure, fasting glucose, physical activity, 
and nutrition intake (β = 0.14, p < 0.001). We further divided people into heavy and 
light smokers using 20 pack-years as the cut-off. Higher triglyceride were found in 
current heavy smokers (β = 0.18, p < 0.001), current light smokers (β = 0.13, p < 0.001), 
as well as in past heavy smokers (β = 0.08, p = 0.037), as compared to never-smokers. 
Moreover, significantly lower high-density lipoprotein cholesterol (HDL-C) were 
observed in current heavy smokers (β = –2.27 mg/dL, p = 0.009).
Conclusions: Cigarette smoking is associated with higher triglyceride in Korean 
men, with the most dramatic effect seen in current smokers with a smoking his-
tory of more than 20 pack-years. HDL-C were also lower in current smokers with 
more than 20 pack-years.
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INTRODUCTION
Dyslipidemia is represented by high blood levels of total 
cholesterol (TC ≥ 240 mg/dL), low-density lipoprotein 
cholesterol (LDL-C ≥ 160 mg/dL), and triglyceride (TG ≥ 
200 mg/dL) and a low level of high-density lipoprotein 
cholesterol (HDL-C < 40 mg/dL) [1]. The serum lipid com-
ponents are associated with cardiovascular disease (CVD) 
risk both independently and in combination [2-4]. Cig-
arette smoking is also a well-known major risk factor 
for atherosclerotic change and CVD [2,5,6]. The results 
of previous studies suggest that cigarette smoking can 
produce oxygen-derived free radicals that damage blood 
lipids. These damaged lipids may promote atherogene-
sis and lead to atherosclerosis [7]. However, the results 
vary in different studies, and the effect of smoking on 
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lipid levels is not well defined [8-10]. 
The prevalence of dyslipidemia among Korean pop-
ulation has been increasing for last 5 years. Nearly four 
out of 10 (40.5 %) adults aged over 30 years old are report-
ed to have dyslipidemia, and the degree is much higher 
in men; overall, nearly half (47.9 %) of Korean men aged 
over 30 years old are reported have dyslipidemia [11]. Ac-
cording to Organization for Economic Cooperation and 
Development Health Statistics 2017, the daily smoking 
rate among Korean men is 31%, which is still higher 
compared to that of average, 23% [12]. The present study 
aims to examine the independent relationship between 




Participants from the Cardiovascular and Metabol-
ic Diseases Etiology Research Center (CMERC) cohort 
provided the sample population for this study [13]. The 
participants were aged between 30 and 64 years old and 
were free from cancer, myocardial infarction, cerebral 
stroke, and heart failure. Health examination of the 
participants was conducted between 2013 and 2018 at 
medical centers in Seoul and Suwon. The study inclu-
sion flow chart is shown in Fig. 1. Of the total of 8,097 
CMERC participants, 2,808 were men. Women were 
excluded from the analysis because the smoking rate 
among women was too low to reveal the association 
between smoking and serum lipid levels (2.88 % were 
current smokers and 3.20 % were past smokers). Of the 
men, 580 reported that they were taking drugs for the 
treatment of hyperlipidemia, statin for the management 
of lipid levels, or omega-3 fatty acids supplementations. 
These patients were excluded from the sample. A fur-
ther 77 past smokers were excluded because their smok-
ing cessation periods were less than 1 year. Finally, 219 
men were excluded because they had missing values for 
potential confounding variables. After these exclusions, 
a total of 1,932 men were included in our study popula-
tion (Fig. 1).
Measurements
Trained interviewers obtained socio-demographic in-
formation, medical, and lifestyle history in in-person 
interviews. Never-smokers were defined as people who 
reported they had smoked no more than 100 cigarettes 
in their lifetime. Past smokers were defined as people 
who reported having smoked ≥ 100 cigarettes, but did 
not smoke at the time of the present investigation. How-
ever, as mentioned above, past smokers with less than 1 
year of smoking cessation period were excluded from 
the analysis. This was done because, as demonstrated 
by previous studies, it is at least after a year after smok-
ing cessation that the characteristics such as the risk of 
CVD incidence [14] or the likelihood of relapse [15] of 
past smokers become distinctively different from those 
of current smokers. Therefore, we assumed ‘past smok-
ers’ to be individuals whose smoking cessation period 
had started more than a year ago. Current smokers were 
defined as those who had smoked ≥ 100 cigarettes and 
who smoked at the time of our investigation. Pack-years 
were calculated for each participant by multiplying 
packs smoked per day by years as a smoker. For example, 
1 pack-year means that the participant smoked one pack 
of cigarettes every day for a year. While there is no gen-
eral consensus on the definition of heavy smoking, we 
used pack-year of 20 as the cut-off in the present study. 
The same criterion was used in previous studies on the 
relationship between smoking and the risk of cancer or 
CVD [16-18]; in addition, in a previous study, the stan-
8,097 People who participated in CMERC
cohort from 2013 to 2018
1,932 Male participants were included 
2,808 Men
5,289







Missing in key variables
77
Past smokers with less than
1 year of smoking cessation 
2,151 Men
Figure 1. Study inclusion flow chart. CMERC, Cardiovascu-
lar and Metabolic Diseases Etiology Research Center.
371
Kim SK, et al. Smoking and blood lipids
www.kjim.orghttps://doi.org/10.3904/kjim.2019.133
dard of 20 pack-year was deemed to be an appropriate 
measure to define heavy smoking in terms of nicotine 
dependency or difficulty in smoking cessation [19]. 
The participants were also asked “Are you currently 
drinking alcohol?” If they said “No,” they were consid-
ered as non-drinkers. Others were considered as current 
drinkers. Among current drinkers, people who said they 
drank more than twice a week and also drank more than 
7 units of alcohol at once were considered to be high-
risk drinkers. 
Information about dietary intake was obtained by us-
ing a semi-quantitative food frequency questionnaire 
developed for the Korea National Health and Nutrition 
Examination Survey [20]. Daily total energy intake (kcal), 
carbohydrate intake (g), and fat intake (g) were calculated. 
The participants were asked about the average consump-
tion frequency and the amounts of 112 types of food con-
sumed throughout the preceding year. Physical activity 
was measured by the Korean version of the International 
Physical Activity Questionnaire (IPAQ)-Short Form. The 
participants were divided into three groups according to 
IPAQ guidelines: low, moderate, and high [21,22].
The participants were asked to fast for a minimum 
of 8 hours before visiting health examination center. 
Then, the participants’ blood samples were collected, 
and laboratory tests were performed in a central labo-
ratory (Seoul Clinical Laboratories R&D Center, Seoul, 
Korea). Serum fasting glucose was measured using a 
colorimetric method and an autoanalyzer (ADVIA 1800 
Auto Analyzer, Siemens Medical Solutions, Malvern, PA, 
USA). Serum TC, HDL-C, and TG were measured using 
automated enzymatic techniques. LDL-C was calculated 
using Friedewald’s equation [23].
Body weight and height were measured using stan-
dardized techniques and equipment. The participants 
were asked to wear light indoor clothing without shoes 
for weight and height measurements. Body mass index 
(BMI) was calculated as weight divided by height squared 
(kg/m2). Blood pressure was measured three times after 
a 5-minute rest in the sitting position via the right arm 
using an electronic manometer (HEM-7080IC, Omron 
Healthcare Co. Ltd., Kyoto, Japan). The average of the 
three values was used for further analysis.
Ethics statement
All participants provided written informed consent, 
and the study protocol was approved by the Institution-
al Review Boards of Severance Hospital, Yonsei Uni-
versity Health System, Seoul, Korea (4-2013-0661) and 
Ajou University Hospital, Suwon, Korea (AJIRB-BMR-
SUR-13-272). 
Statistical analyses
Basic characteristics of the study population are pre-
sented as means with standard deviation, medians with 
interquartile range, or numbers with percentage. T-test 
and chi-square test were used to identify significant re-
lationships between basic characteristics and smoking 
status. Multiple linear regression analysis was used to 
examine the association between cigarette smoking and 
each serum lipid level. In all regression analyses, the 
never-smoker group was used as the reference group. 
Due to their right-skewed distributions, serum glucose 
and TG levels were log-transformed to satisfy the nor-
mality assumption for statistical analysis. For HDL-C 
and TG levels, the least squares means, estimated from 
linear regression models, were derived for convenience 
of interpretation. Least squares mean for one variable is 
the adjusted mean value that controls the effect of the 
major covariates [24]; therefore, we considered it suit-
able for comparing the mean lipid levels of each smoker 
group after controlling the influence of the covariates. 
Age, BMI, alcohol intake, systolic blood pressure, fast-
ing serum glucose, physical activity, and dietary (total 
energy, carbohydrates, and fat) intake were adjusted as 
potential covariates in the regression analyses and least 
squares means analyses. To determine whether indi-
viduals with a higher smoking amount, as measured 
by pack-years, have higher blood lipid levels than those 
without such amount, we conducted linear trend tests 
and multiple comparisons using Tukey’s method. All 
statistical analyses were performed using SAS version 
9.4 (SAS Institute, Cary, NC, USA) and p < 0.05 was con-
sidered to be statistically significant.
RESULTS
General characteristics
Table 1 shows the general characteristics of the study 
population. The mean age was 49.5. Past smokers and 
current smokers amounted to 40.3% (n = 779) and 36.5% 
372 www.kjim.org https://doi.org/10.3904/kjim.2019.133
The Korean Journal of Internal Medicine Vol. 35, No. 2, March 2020
(n = 705) of the total (n = 1,932), respectively. Independent 
t test and chi-square test were performed to establish 
whether the general characteristics of past smokers and 
current smokers differed from those of never-smokers. 
The results showed that, as compared to never-smokers, 
past smokers were older, while current smokers were 
younger, and these differences in age were statistically 
significant (p < 0.001 and p = 0.002, respectively). Systolic 
and diastolic blood pressure, as well as fasting glucose 
levels, were significantly higher in past smokers than in 
never-smokers. Furthermore, current smokers had sig-
nificantly higher measurements of weight and height, 
and a higher fasting glucose level than the never-smok-
er group. For alcohol drinking, current smokers drank 
more than never-smokers. The proportion of high-risk 
drinkers was the highest in the current smoker group 
(48.2%), which is nearly half, followed by past smoker 
group (29.9%) and never-smoker group (19.4%). In ad-
dition, current smokers were less physically active and 
consumed more calories, carbohydrate, protein, and fat 
than never-smokers. For blood lipid levels, the TG lev-
els of current and past smokers were significantly much 
higher as compared to that of never-smokers (34 mg/dL 
higher, p < 0.001 and 15 mg/dL higher, p = 0.027, current 
smokers and past smokers, respectively). For other lip-
id components, there was no significant difference be-
tween each smoker group. 





Never-smoker   
(n = 448)
Past smoker       
(n = 779)
p valuea
Current smoker      
(n = 705)
p valuea
Age, yr 49.5 ± 9.6 48.4 ± 10.5 52.8 ± 8.3 < 0.001 46.5 ± 9.2 0.002
Weight, kg 72.8 ± 10.2 72.0 ± 9.5 72.0 ± 9.8 0.977 74.1 ± 10.9 0.001
Height, cm 170.9 ± 6.0 170.7 ± 6.2 170.0 ± 5.9 0.060 171.9 ± 5.9 0.001
Body mass index, kg/m2 24.9 ± 2.9 24.7 ± 2.8 24.9 ± 2.7 0.277 25.0 ± 3.1 0.055
Systolic blood pressure, mmHg 124.4 ± 13.7 123.4 ± 13.1 125.8 ± 14.0 0.003 123.6 ± 13.6 0.862
Diastolic blood pressure, mmHg 80.3 ± 10.0 79.5 ± 9.5 81.0 ± 10.1 0.012 80.0 ± 10.1 0.449
Fasting serum glucose, mg/dL 94 (87–103) 91 (85–100) 96 (89–105) < 0.001 94 (86–102) 0.006
TC, mg/dL 196.5 ± 33.6 194.9 ± 33.6 196.6 ± 34.0 0.375 197.4 ± 33.0 0.213
HDL-C, mg/dL 50.2 ± 12.2 50.6 ± 12.5 50.8 ± 12.4 0.798 49.3 ± 11.79 0.077
LDL-C, mg/dL 114.7 ± 31.3 116.4 ± 30.9 115.4 ± 31.1 0.614 112.8 ± 31.7 0.059
TG, mg/dL 133 (93–188) 115 (84–168) 130 (92–176) 0.027 149 (103–210) < 0.001
Energy intake, kcal/day 2,670.5 ± 925.7 2,504.9 ± 856.7 2,544.5 ± 817.4 0.422 2,915.1 ± 1,025.3 < 0.001
Carbohydrate intake, g/day 417.2 ± 128.5 403.9 ± 119.5 405.6 ± 119.7 0.816 438.4 ± 140.3 < 0.001
Protein intake, g/day 83.5 ± 37.2 80.6 ± 35.7 80.1 ± 32.8 0.787 89.2 ± 41.7 < 0.001
Fat intake, g/day 50.4 ± 28.5 48.4 ± 27.8 46.8 ± 24.6 0.304 55.7 ± 31.9 < 0.001
Current alcohol intake
Non-drinker 97 (5.0) 29 (6.5) 58 (7.5) < 0.001 10 (1.4) < 0.001
Moderate drinker 1,175 (60.8) 332 (74.1) 488 (62.6) 355 (50.4)
High-risk drinker 660 (34.2) 87 (19.4) 233 (29.9) 340 (48.2)
Physical activity
Low 773 (40.0) 157 (35.0) 292 (37.5) 0.425 324 (46.0) 0.001
Moderate 720 (37.3) 186 (41.5) 294 (37.7) 240 (34.0)
High 439 (22.7) 105 (23.4) 193 (24.8) 141 (20.0)
Values are presented as mean ± SD, median (interquartile range), or number (%).
TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglyceride.
aA p values are calculated by independent t tests or chi-square tests, compared to non-smokers.
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Smoking status and lipid profile
Associations between blood lipid levels and several vari-
ables, including smoking status, were determined using 
multiple linear regression analysis (Table 2). BMI was 
significantly strongly associated with altered levels of 
all serum lipids that were measured. Individuals with 
higher BMI had higher levels of TC, LDL-C, and log-
TG, but lower HDL-C levels. Alcohol drinking was pos-
itively associated with HDL-C levels, but negatively with 
LDL-C levels. Systolic blood pressure was positively 
associated with TC, LDL-C, and log-TG levels. Serum 
glucose levels were negatively associated with LDL-C 
levels, but positively associated with log-TG levels. The 
participants who were more physically active tended to 
have higher HDL-C and lower log-TG levels as com-
pared to their less active counterparts. Total energy in-
take was significantly positively associated with HDL-C 
and log-TG, whereas the association with LDL-C was 
significantly negative. Carbohydrate intake was signifi-
cantly associated with lower HDL-C and log-TG levels, 
while fat intake was significantly associated with higher 
LDL-C, but lower log-TG. 
With regard to the reference group, lipid measure-
ments of past smokers were not significantly different 
(TC was 1.85 mg/dL higher, p = 0.360; HDL-C was 0.30 
mg/dL higher, p = 0.658; LDL-C was 0.22 mg/dL higher, 
p = 0.907; and log-TG was 0.05 higher, p = 0.083). In cur-
rent smokers, HDL-C was significantly lower (1.82 mg/
dL lower, p = 0.010), while log-TG was significantly high-
er (0.14 higher, p < 0.001) than in never-smokers. For TC 
(2.59 mg/dL higher, p = 0.215) and LDL-C (0.07 mg/dL 
lower, p = 0.930), no significant difference between cur-
rent smokers and never-smokers was observed. In addi-
tion, the independent association between the non-log-
transformed TG value and smoking status was found to 
be consistent with the results of the analysis with log-TG 
(data not shown in table). In past smokers, TG was not 
significantly different from that of never-smokers (6.62 
mg/dL higher, standardized β = 0.03, p = 0.277). Current 
smokers had significantly higher TG than never-smok-
ers (22.88 mg/dL higher, standardized β = 0.10, p < 0.001). 
Using the method of least squares (adjusted for the 
same covariates as the preceding analysis), the mean TG 
level of current smokers was 169.79 mg/dL, which was 
significantly higher than that of never-smokers (22.88 
mg/dL higher than never-smokers, p < 0.001) and past 
smokers (16.26 mg/dL higher than past smokers, p = 
0.004). No significant difference in adjusted means of 
TG level between never-smokers and past smokers was 
found; an adjusted mean of TG level of past smokers was 
153.53 mg/dL and it was 6.62 mg/dL higher than that of 
never-smokers, p = 0.277. The adjusted mean HDL lev-
el of current smokers was 48.94 mg/dL, which was sig-
nificantly lower than that of never-smokers (2.56 mg/dL 
lower, p = 0.010) and past smokers (3.39 mg/dL lower, p 
= 0.001). Similarly to TG level, there was no significant 
difference in HDL-C level between never-smokers and 
past smokers; HDL-C level of past smokers (51.07 mg/dL) 
which was 0.30 mg/dL higher than that of never-smok-
ers (50.77 mg/dL, p = 0.658).
For further analysis, we subdivided each smoker group 
based on the amount of smoking using 20 pack-years as 
the cut-off between light and heavy smokers. The par-
ticipants were divided into the following five groups: 
(1) never-smokers, (2) past light smokers, (3) past heavy 
smokers, (4) current light smokers, and (5) current heavy 
smokers. Table 3 shows the results from multiple lin-
ear regression analysis, using the never-smokers as the 
reference group. Past smokers with fewer than 20 pack-
years showed no significant difference in blood lipid 
levels. However, past smokers with more than 20 pack-
years had a higher log-TG level as compared to that of 
never-smokers (log-TG was 0.08 higher, p = 0.037). For 
current smokers, current light smokers (log-TG was 0.13 
higher, p < 0.001) and current heavy smokers (log-TG 
was 0.18 higher, p < 0.001) had significantly higher log-
TG levels than never-smokers. We observed a higher 
log-TG level in current heavy smokers, with more than 
20 pack-years, than in current light smokers, with few-
er than 20 pack-years. The independent association be-
tween the non-log-transformed TG value and smoking 
status with the amount of smoking was additionally eval-
uated (data not shown in table). Past light smokers and 
past heavy smokers were not significantly different in 
terms of their TG level compared to never-smokers (5.75 
mg/dL higher, p = 0.378 in past light smokers and 10.59 
mg/dL higher, p = 0.192). At the same time, current light 
smokers had a significantly higher TG level than nev-
er-smokers (15.90 mg/dL higher, p = 0.027), and current 
heavy smokers had a much higher TG level than nev-
er-smokers (31.99 mg/dL higher, p < 0.001). 
Current heavy smokers also had significantly lower 
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HDL-C levels as compared to those of never-smokers 
(2.27 mg/dL lower, p = 0.009); however, HDL-C level of 
current light smokers was not significantly different 
from that of never-smokers (1.46 mg/dL lower than nev-
er smokers, p = 0.072). 
The least squares means were also calculated for TG 
levels in each of the five smoker groups that were ad-
justed for potential variables as described above. The re-
sults for this analysis are presented in Table 4. Current 
heavy smokers had the highest adjusted mean TG levels 
(least squares means = 178.57 mg/dL), and this value was 
significantly higher than that of current light smokers 
(mean difference = 16.09 mg/dL, p = 0.041), past heavy 
smokers (mean difference = 21.40 mg/dL, p = 0.013), past 
light smokers (mean difference = 26.24 mg/dL, p < 0.001, 
and never-smokers (mean difference = 31.99 mg/dL, p < 
0.001). Furthermore, current light smokers had a signifi-
cantly higher adjusted mean TG levels compared to nev-
er-smokers (mean difference = 15.90 mg/dL, p = 0.027); 
however, when compared to past smoker groups, the 
difference did not reach statistical significance. Beyond 
the significantly higher TG levels in current smokers, 
there was no significant difference between the adjust-
ed means of the past smoker groups and never- smoker 
group. 
Blood lipid levels for each smoker group according 
to smoking amounts
We evaluated whether people with a higher smoking 
amount have higher serum lipid levels. Due to difficul-
ties in interpretation, past smokers were excluded from 
this analysis. We first performed linear trend analysis, 
again dividing current smokers into light and heavy 
smokers using 20 pack-years as the cut-off. Of the four 
serum lipids measured, the crude means of HDL-C 
and TG showed a significant linear trend (p for trend = 
0.037 for HDL-C and p for trend < 0.001 for TG). With 
an increase of the amount of smoking, HDL-C level de-
creased, while TG level increased. Fig. 2 shows the de-
tailed information on the means of lipid levels of each 
smoker group.
Next, we performed multiple comparison analysis of 
the crude means of TG level using Tukey’s method and 
a studentized range of 19.11 (data not shown in table). 
The results showed a significantly higher TG level in 
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and heavy smokers (mean difference of 43.99 mg/dL, p 
< 0.001), as compared to never-smokers. However, we 
found no significant difference between the TG levels 
of light and heavy smokers (mean difference of 12.62 
mg/dL, p = 0.307). We also conducted multiple compar-
isons for the (crude) means of HDL-C (data not shown 
in table). Although HDL-C was low in proportion to the 
amount of smoked cigarettes, the differences in HDL-C 
level were not statistically significant (studentized range 
was 2.08; mean difference between never-smoker and 
light smoker = 0.85 mg/dL, p = 0.562; mean difference 
between never-smoker and heavy smoker = 1.88 mg/dL, 
p = 0.090; mean difference between light smoker and 
heavy smoker = 1.03 mg/dL, p = 0.500). We also evaluated 
the changes of TG and HDL-C levels with an increase of 
smoked pack-year among current smokers (Fig. 3).
DISCUSSION
In the present study of apparently healthy Korean men, 
cigarette smoking was found to be associated with higher 
Table 4. Comparison of blood triglyceride levels between each of the smoking categories
Name
Group 1, mg/dL Group 2, mg/dL Group 1–2, mg/dL
p value
Mean ± SE Mean ± SE Mean (95% CI)
Current heavy smokera 178.57 ± 5.82
Current light smoker 162.48 ± 5.30 16.09 (0.70 to 31.48) 0.041
Past heavy smoker 157.17 ± 6.39 21.40 (4.58 to 38.23) 0.013
Past light smoker 152.33 ± 4.46 26.24 (11.73 to 40.74) < 0.001
Never-smoker 146.58 ± 4.82 31.99 (16.90 to 47.08) < 0.001
Current light smokera 162.48 ± 5.30
Past heavy smoker 157.17 ± 6.39 5.31 (–11.54 to 22.17) 0.537
Past light smoker 152.33 ± 4.46 10.15 (–3.74 to 24.04) 0.152
Never-smoker 146.58 ± 4.82 15.90 (1.84 to 29.96) 0.027
Past heavy smokera 157.17 ± 6.39
Past light smoker 152.33 ± 4.46 4.83 (–10.27 to 19.94) 0.530
Never-smoker 146.58 ± 4.82 10.59 (–5.31 to 26.48) 0.192
Past light smokera 152.33 ± 4.46
Never-smoker 146.58 ± 4.82 5.75 (–7.05 to 18.55) 0.378
Values are least square means adjusted for age, body mass index, alcohol drinking, systolic blood pressure, log-transformed 
fasting serum glucose, physical activity and energy, carbohydrate and fat intake.
SE, standard error; CI, confidence interval.
a Past/current light smokers are past/current smokers with less than 20 pack-year, past/current heavy smokers are past/current 












TC HDL-C LDL-C TG
Never smoker
Current light smoker 
Current heavy smoker 
p for trend = 0.314
p for trend = 0.037
p for trend = 0.056
p for trend < 0.001a
 
Figure 2. Mean of each lipid level according to current 
smoking status among Korean men. Past smokers who do 
not smoke currently were excluded. TC, total cholester-
ol; HDLC, high-density lipoprotein cholesterol; LDL-C, 
low-density lipoprotein cholesterol; TG, triglyceride. aCal-
culated from log-transformed TG.
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serum TG levels, and current smokers who had smoked 
more than 20 pack-years had much higher TG levels 
than individuals who had not. When we further divided 
smokers into light and heavy smoking groups using 20 
pack-years as the cut-off, both current light and heavy 
smokers were found to have higher TG levels as com-
pared to that of never-smokers, with a greater difference 
between current heavy smokers and never-smokers. 
Similarly, in other analyses, TG level was remarkably 
higher in current heavy smokers as compared to cor-
responding levels in other groups. Past heavy smokers 
were found to have a higher TG level in some analyses, 
as compared to never-smokers. For other lipid compo-
nents, a lower HDL level was associated with current 
heavy smoking. Except for current heavy smokers, there 
was no significant difference in HDL-C level among 
other smoker groups. Meanwhile, for current smokers, 
a higher smoking amount was much worse than a lower 
amount. Our finding that male smokers had higher TG 
levels as compared to male non-smokers is consistent 
with the results of a number of previous studies [25-34]. 
Our results cohere with those reported in some previ-
ous studies that smokers with higher smoking amounts 
had higher TG levels as compared to individuals with 
relatively lower smoking amounts [28,33,34]. However, 
in several areas, our results were different from those 
reported previous; this applies to our finding that smok-
ing had little impact on TG levels in men or that there 
was no significant difference in triglyceride levels be-
tween male smoking ‘quitters’ and smoking ‘continu-
ers’ [35]. The lower level of HDL in smokers found in 
the present study was similar to the results of previous 
studies [8-10,36,37]. A recent review demonstrated that 
LDL-C is the least affected lipid component in smokers 
[38]; likewise, in the present study, we did not observe 
any significant association between cigarette smoking 
and LDL-C level.
In the present study, TG levels were found to be higher 
in current smokers, particularly in current heavy smok-
ers. However, as revealed by baseline characteristics, 
the rate of high-risk drinkers among current smokers 
was 48.2%, which is much higher than that among past 
smokers (29.9%) and non-smokers (19.4%); therefore, al-
cohol drinking status and smoking status are strongly 
related to each other. Although alcohol drinking level 
was adjusted in regression analysis, there is a possibil-
ity that “heavy alcohol drinkers,” not “heavy smokers,” 
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Figure 3. (A, B) Correlation between smoked pack-years and lipid levels among current smokers. TG, triglyceride; HDL-C, 
high-density lipoprotein cholesterol. aUnadjusted Pearson’s correlation coefficient. bAdjusted Pearson’s correlation coefficient, 
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stratified the participants into three groups according to 
their current drinking status (non-drinkers, moderate 
drinkers, and high-risk drinkers) and re-analyzed the 
association between smoking status and TG levels. The 
results are reported in Supplementary Table 1. Most par-
ticipants (60.8%, n = 1,175) were moderate drinkers, and 
only 5.0% (n = 97) were non-drinkers. In both moderate 
drinkers and high-risk drinkers, current light smoking 
and current heavy smoking were significantly associated 
with higher log-TG levels, which is similar with the re-
sult in the total sample (n = 1,932). However, this pattern 
was not observed in non-drinkers, which might be due 
to the small number of current smokers among high-
risk drinkers.
Several previous studies revealed gender differences 
in how smoking affects lipid levels [26,41,42]; but the re-
sults of these studies were not conclusive. In order to 
investigate whether the association between cigarette 
smoking and serum lipid levels differs between two 
genders in our study population, we conducted addi-
tional analysis with a total of 3,747 women. Similarly to 
our results on male smokers, we found no significant 
association of smoking with TC and LDL-C in women. 
However, unlike the results on male smokers, female 
past light smokers had significantly higher HDL-C than 
female never-smokers, and there was a significantly 
strong interaction between gender and smoking status 
(p = 0.0282). Female current light smokers also had a sig-
nificantly higher TG level than female never-smokers. 
However, unlike in male smokers, TG level of female 
past heavy smokers and current heavy smokers was not 
significantly different from that of never-smokers (Sup-
plementary Table 2).
In the present study, information on nutritional in-
take was included as the covariate in the analysis of the 
association between smoking and lipid levels. Sever-
al previous studies reported that higher carbohydrate 
intake generally leads to lower HDL-C and higher TG 
[43-45]. In this study, a higher carbohydrate intake was 
associated with a lower HDL-C level, but TG was signifi-
cantly lower in individuals with a higher carbohydrate 
intake, which is inconsistent with the results of previous 
studies. According to some studies, not only the quan-
tity of carbohydrate consumed, but also the source and 
type of carbohydrate consumed are also (albeit different-
ly) associated with cardiovascular risk factors [46,47]. 
Of note, many studies on the relationship between 
carbohydrate intake and blood lipid levels have been 
conducted in Western countries. Considering that Asian 
and Western populations have very different aspects of 
carbohydrate intake [48], our results may differ from 
those of previous studies when it comes to the relation-
ship between carbohydrate intake and TG level. Further 
research on dietary intake and lipid levels among the 
Korean population is needed. 
Although the mechanism of how smoking affects se-
rum lipid levels is not fully clear yet, several possible 
explanations can be proposed. In one model, rising 
catecholamine levels may cause a surge in circulating 
free fatty acids that stimulates hepatic TG synthesis and 
changes lipid metabolism [49,50]. Another model is that 
smoking evokes reduced activity of lecithin-cholester-
ol acyltransferase, the enzyme in charge of esterifying 
free cholesterol, which results in altered lipid metabo-
lism [37,51]. The third possibility of higher TG level in 
smokers is that TG metabolism is slower in smokers, 
as lipoprotein lipase activity, which affects TG levels, is 
decreased in smokers [52]. 
The present study has several strengths compared to 
previous studies. First, our sample included apparently 
healthy subjects free of major CVD. Therefore, we inves-
tigated the impact of smoking on blood lipid profiles 
before progression to clinically apparent cardiovascu-
lar pathogenesis. Second, we identified an independent 
association between smoking and blood lipid levels by 
excluding individuals taking any lipid-control medi-
cations or receiving other treatments, as well as by ad-
ditionally adjusting for variables that may influence 
lipid levels. Third, few previous studies that evaluated 
the effect of smoking on blood lipid profiles have ac-
counted for nutrient intake and physical activity. Since 
our analysis considered the effect of these variables on 
lipid levels, we were able to more directly evaluate the 
independent association between cigarette smoking and 
blood lipid levels. Finally, our study adequately reflects 
the smoking behavior of the general population in Ko-
rea. According to the 2017 Korean National Health and 
Nutrition Survey data, among the men in the same age 
(30 to 64 years old), current smoking rate was 37.25%, and 
past smoking rate was 33.43%, with a lifetime smoking 
experience rate of 70.68%. The lifetime smoking experi-
ence rate of our study population was 76.80%, which is 
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similar to that of the general population. Therefore, it is 
expected that the results of this study can be extended to 
general population.
 Our study has several limitations. First, due to the 
cross-sectional study design, we could not investigate 
the longitudinal effect of cigarette smoking on blood 
lipid levels. Future longitudinal research could confirm 
that increased serum TG levels and decreased HDL level 
result from smoking habits and establish a cause-and-
effect relationship. Second, considering that informa-
tion on smoking was obtained by in-person interviews, 
inaccuracy may be present in the data from measure-
ment errors and recall bias [53]. However, current smok-
ing status is not likely to be an object of recall bias. Ad-
ditionally, in order to determine the dose of smoking in 
pack-years, we examined the reliability of two types of 
information: age at smoking initiation and amount of 
smoking per day. A part of our study population had re-
ceived health examinations in years 1999, 2005, or 2010 
to 2011 in a separate study. Smoking data obtained in 
1999, 2005, or 2010 to 2011 examinations were matched 
with smoking data from the CMERC cohort. A total of 
135 pairs were derived from these data, and Spearman’s 
correlation analyses were conducted. The correlation 
coefficients for the age at smoking initiation and for the 
amount of smoking per day were 0.49983 (p < 0.001) and 
0.50121 (p < 0.001), respectively. Third, there could have 
been unknown or unexpected confounding variables in 
lifestyles between smokers and never-smokers. Howev-
er, major causes of dyslipidemia, including obesity, al-
cohol intake, diabetes, and other lifestyle factors, were 
considered in the present study. Fourth, we could not 
measure the impact of passive smoking. According to 
previous studies, passive smoking is associated with in-
creased risk of CVD [54,55]; however, its effect on CVD is 
much smaller than that of active smoking, according to 
a meta-analysis study [55].
In Korea, the proportion of men aged over 30 years 
old and having hypertriglyceridemia is more than twice 
higher than that of women (24.8% vs. 11.0%) [11]. These 
gender differences might be attributable to the differ-
ences in the practice of health behaviors between two 
genders, such as alcohol drinking pattern and cigarette 
smoking. As hypertriglyceridemia is an independent 
risk factor for CVD including coronary heart disease 
[56,57], the management of TG is crucial. In this regard, 
the results of the present study are meaningful because 
we demonstrated that cigarette smoking alone increases 
TG level, even after ruling out the effects of common-
ly-known risk factors (obesity, blood pressure, glucose, 
nutritional intake, alcohol drinking, and exercise) on 
TG level. Furthermore, the proportion of Korean men 
over 30 with hypo-HDL cholesterolemia amounts to 
27.2% [11]. Elevating HDL-C is helpful for the preven-
tion of CVD, as it is known to be a “protective particle” 
that improves endothelial function and limits athero-
sclerosis progression [10,50]. In the present study, cur-
rent heavy smoking was shown to be associated with a 
lower HDL-C level, which suggests the possibility that 
cigarette smoking might be a risk factor for lowering 
HDL-C. 
In conclusion, in the present study, we found that cur-
rent cigarette smoking is associated with high TG levels 
in apparently healthy Korean males. Additionally, we 
found that people with a higher number of cigarettes 
smoked in pack-years had higher serum TG levels. For 
current smokers with over 20 pack-years, not only high-
er TG, but also lower HDL-C were observed. The lipid 
levels of past smokers were not considerably different 
from those of never-smokers. Further research is need-
ed to clarify the effect of cigarette smoking on blood 
lipid profiles and to discover the mechanism by which 
smoking alters lipid metabolism.
KEY MESSAGE
1. In apparently healthy Korean male population, 
current cigarette smoking was found to be as-
sociated with higher serum triglyceride (TG) 
levels, and heavy smokers had higher TG levels 
than light smokers.
2. Current smokers with over 20 pack-years had 
not only higher log-triglycerides levels, but also 
lower high-density lipoprotein levels.
3. The lipid levels of past smokers (particularly 
past smokers with fewer than 20 pack-years) 
were almost identical to those of never-smokers.
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